Monoamine oxidase B (MAO-B), predominantly expressed in glial cells, plays an important role in neurotransmitter regulation, and MAO-B activity relates to several neuronal diseases. Here, we aimed to develop a radiofluorinated MAO-B imaging probe based on the structure of a selective MAO-B inhibitor, MD-230254. We synthesized and evaluated a series of compounds in vitro and in vivo. A series of fluorinated analogs of MD-230254 were synthesized and evaluated for inhibitory potency and selectivity toward MAO-B. 5-[4-(2-[18F]Fluorobenzyloxy)phenyl]-3-(2-cyanoethyl)-1,3,4-oxadiazol-2(3H)-one (2-[18F]FBPO) was synthesized from a corresponding tributylstannyl precursor and [18F]CH3COOF. Biodistribution after intravenous injection of 2-[18F]FBPO was evaluated in male ddY mice with or without pretreatment by inhibitors. Among the compounds synthesized and evaluated, 2-FBPO showed high inhibitory potency and selectivity toward MAO-B comparable with MD-230254. 2-[18F]FBPO was successfully synthesized by an electrophilic reaction with a high radiochemical purity of more than 99%. 2-[18F]FBPO was efficiently taken up by the brain and showed rapid blood clearance, which provided a brain/blood radioactivity ratio of 3.7 at 90 minutes postinjection. The brain radioactivity was significantly decreased by pretreatment with an MAO-B selective inhibitor. The great potential of 2-[18F]FBPO as an MAO-B imaging probe, applicable to a variety of diseases, is indicated.
单胺氧化酶 B(MAO-B)主要表达于神经胶质细胞,在神经递质调节中发挥着重要作用,MAO-B 的活性与多种神经元疾病有关。在此,我们旨在根据一种选择性 MAO-B
抑制剂 MD-230254 的结构开发一种放射性
氟化 MAO-B 成像探针。我们合成并在体外和体内评估了一系列化合物。我们合成了一系列 MD-230254 的含
氟类似物,并评估了它们对 MAO-B 的抑制效力和选择性。5-[4-(2-[18F]
氟苄氧基)苯基]-3-(2-
氰乙基)-1,3,4-恶二唑-2(3H)-酮(2-[18F]F
BPO)由相应的三
丁基锡前体和[18F]CH3COOF合成。评估了雄性 ddY 小鼠静脉注射 2-[18F]F
BPO 后的
生物分布情况,无论是否经过
抑制剂预处理。在合成和评估的化合物中,2-F
BPO 对 MAO-B 具有很高的抑制效力和选择性,可与 MD-230254 相媲美。通过亲电反应成功合成了 2-[18F]F
BPO,其放射
化学纯度高达 99% 以上。2-[18F]F
BPO能被大脑有效吸收,并在血液中迅速清除,注射后90分钟的脑/血放射性比为3.7。在使用 MAO-B 选择性
抑制剂预处理后,脑部放射性明显降低。2-[18F]F
BPO作为一种MAO-B成像探针,适用于多种疾病,具有巨大的潜力。